Nature's Sunshine Products Valuation
Is NATR undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of NATR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: NATR ($15.87) is trading below our estimate of fair value ($37.44)
Significantly Below Fair Value: NATR is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for NATR?
Key metric: As NATR is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is NATR's PE Ratio? | |
|---|---|
| PE Ratio | 17.3x |
| Earnings | US$16.98m |
| Market Cap | US$295.61m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.5x |
| Enterprise Value/EBITDA | 5.9x |
| PEG Ratio | 2.7x |
Price to Earnings Ratio vs Peers
How does NATR's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 32.8x | ||
LFVN LifeVantage | 41.4x | n/a | US$173.2m |
THRN Thorne HealthTech | 27.1x | 57.2% | US$550.6m |
HKHC Horizon Kinetics Holding | 37x | n/a | US$722.1m |
MED Medifast | 25.5x | 4.4% | US$193.2m |
NATR Nature's Sunshine Products | 17.3x | 6.4% | US$295.6m |
Price-To-Earnings vs Peers: NATR is good value based on its Price-To-Earnings Ratio (17.3x) compared to the peer average (34.7x).
Price to Earnings Ratio vs Industry
How does NATR's PE Ratio compare vs other companies in the US Personal Products Industry?
| 1 Company | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
NEPT.F Neptune Wellness Solutions | n/a | n/a | US$4.00 |
| 1 Company | Estimated Growth | Market Cap |
|---|
Price-To-Earnings vs Industry: NATR is good value based on its Price-To-Earnings Ratio (17.3x) compared to the North American Personal Products industry average (26.5x).
Price to Earnings Ratio vs Fair Ratio
What is NATR's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 17.3x |
| Fair PE Ratio | 15.6x |
Price-To-Earnings vs Fair Ratio: NATR is expensive based on its Price-To-Earnings Ratio (17.3x) compared to the estimated Fair Price-To-Earnings Ratio (15.6x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | US$15.87 | US$21.00 +32.3% | 9.5% | US$23.00 | US$19.00 | n/a | 2 |
| Nov ’25 | US$13.11 | US$19.50 +48.7% | 7.7% | US$21.00 | US$18.00 | n/a | 2 |
| Oct ’25 | US$13.36 | US$19.50 +46.0% | 7.7% | US$21.00 | US$18.00 | n/a | 2 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.
Discover undervalued companies
Reynolds Consumer Products
US$5.7b
Produces and sells products in cooking, waste and storage, and tableware product categories in the United States and internationally.
REYN
US$27.47
7D
-0.3%
1Y
3.8%
USANA Health Sciences
US$768.9m
Develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe.
USNA
US$39.38
7D
-4.6%
1Y
-14.8%
Kimberly-Clark de México S. A. B. de C. V
Mex$86.8b
Manufactures, distributes, and sells disposable products in Mexico.
KCDM.Y
Mex$7.05
7D
-0.3%
1Y
-30.2%